Andrew Teo1, Wina Hasang2, Louise M Randall2, Gaoqian Feng3, Lauren Bell4, Holger Unger1, Christine Langer3, James G Beeson3, Peter M Siba5, Ivo Mueller6, Malcolm E Molyneux7, Graham V Brown4, Stephen J Rogerson2. 1. Department of Medicine Doherty Institute. 2. Department of Medicine Victorian Infectious Diseases Service Doherty Institute. 3. Burnet Institute, Melbourne, Australia. 4. Nossal Institute for Global Health, University of Melbourne. 5. Papua New Guinea Institute of Medical Research, Goroka. 6. Walter and Eliza Hall Institute of Medical Research, Parkville Barcelona Center for International Health Research, Spain. 7. Malawi-Liverpool-Wellcome Trust Clinical Research Programme College of Medicine, Blantyre Liverpool School of Tropical Medicine, United Kingdom.
Abstract
BACKGROUND: As malaria control is intensified, pregnant women may be less exposed to malaria, thus affecting the acquisition of protective antibody. METHODS: Plasma samples were collected from Malawian and Papua New Guinean (PNG) pregnant women enrolled over 7-year periods, during which malaria prevalence fell by over two thirds. Immunoglobulin G (IgG) levels to schizont extract, merozoite antigens, and VAR2CSA-DBL5ε were measured by enzyme-linked immunosorbent assay (ELISA). Levels of IgG to variant surface antigens of infected erythrocytes (IEs) and merozoites and levels of opsonizing IgG to IEs were measured by flow cytometry. RESULTS: In both settings, levels of antibodies in pregnant women to recombinant antigens and to intact IEs but not of opsonizing antibodies decreased over time. After adjustment for coverage with insecticide-treated bed nets (ITNs), these differences disappeared in the Malawian cohort, whereas in the PNG cohort, time was independently associated with a decrease in several antibody responses measured by ELISA. CONCLUSIONS: The impact of falling parasite prevalence on anti-Plasmodium falciparum serological indicators in pregnant women varies by setting. Increased ITN coverage may affect development of antibodies to recombinant antigens, but levels of opsonizing IgG remained stable over time. Opsonizing IgG against placental-binding IEs may persist, thus offering longer-lasting protection against malaria during pregnancy.
BACKGROUND: As malaria control is intensified, pregnant women may be less exposed to malaria, thus affecting the acquisition of protective antibody. METHODS: Plasma samples were collected from Malawian and Papua New Guinean (PNG) pregnant women enrolled over 7-year periods, during which malaria prevalence fell by over two thirds. Immunoglobulin G (IgG) levels to schizont extract, merozoite antigens, and VAR2CSA-DBL5ε were measured by enzyme-linked immunosorbent assay (ELISA). Levels of IgG to variant surface antigens of infected erythrocytes (IEs) and merozoites and levels of opsonizing IgG to IEs were measured by flow cytometry. RESULTS: In both settings, levels of antibodies in pregnant women to recombinant antigens and to intact IEs but not of opsonizing antibodies decreased over time. After adjustment for coverage with insecticide-treated bed nets (ITNs), these differences disappeared in the Malawian cohort, whereas in the PNG cohort, time was independently associated with a decrease in several antibody responses measured by ELISA. CONCLUSIONS: The impact of falling parasite prevalence on anti-Plasmodium falciparum serological indicators in pregnant women varies by setting. Increased ITN coverage may affect development of antibodies to recombinant antigens, but levels of opsonizing IgG remained stable over time. Opsonizing IgG against placental-binding IEs may persist, thus offering longer-lasting protection against malaria during pregnancy.
Authors: John M Benjamin; Brioni R Moore; Sam Salman; Madhu Page-Sharp; Somoyang Tawat; Gumal Yadi; Lina Lorry; Peter M Siba; Kevin T Batty; Leanne J Robinson; Ivo Mueller; Timothy M E Davis Journal: Antimicrob Agents Chemother Date: 2015-05-11 Impact factor: 5.191
Authors: Justin Doritchamou; Andrew Teo; Robert Morrison; Gunjan Arora; Jennifer Kwan; Javier Manzella-Lapeira; Sarimar Medina-Maldonado; Jean Langhorne; Lars Hviid; David L Narum; Alassane Dicko; Michal Fried; Patrick E Duffy Journal: Infect Immun Date: 2019-06-20 Impact factor: 3.441
Authors: Jessica E Atwell; Bhagvanji Thumar; Leanne J Robinson; Roselyn Tobby; Phantica Yambo; Maria Ome-Kaius; Peter M Siba; Holger W Unger; Stephen J Rogerson; Christopher L King; Ruth A Karron Journal: J Infect Dis Date: 2015-08-03 Impact factor: 5.226
Authors: Holger Werner Unger; Maria Ome-Kaius; Stephan Karl; Dupain Singirok; Peter Siba; Jane Walker; Regina Alice Wangnapi; Ivo Mueller; Stephen John Rogerson Journal: BMC Pregnancy Childbirth Date: 2015-04-03 Impact factor: 3.007
Authors: Andrew Teo; Wina Hasang; Louise M Randall; Holger W Unger; Peter M Siba; Ivo Mueller; Graham V Brown; Stephen J Rogerson Journal: Malar J Date: 2015-05-26 Impact factor: 2.979
Authors: Alexandra J Umbers; Holger W Unger; Anna Rosanas-Urgell; Regina A Wangnapi; Johanna H Kattenberg; Shadrach Jally; Selina Silim; Elvin Lufele; Stephan Karl; Maria Ome-Kaius; Leanne J Robinson; Stephen J Rogerson; Ivo Mueller Journal: Malar J Date: 2015-10-19 Impact factor: 2.979
Authors: Upeksha P Chandrasiri; Freya J I Fowkes; Jack S Richards; Christine Langer; Yue-Mei Fan; Steve M Taylor; James G Beeson; Kathryn G Dewey; Kenneth Maleta; Per Ashorn; Stephen J Rogerson Journal: Malar J Date: 2015-05-10 Impact factor: 2.979